A resected case of Mycobacterium szulgai pulmonary disease. 1998

K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
Department of Infection and Inflammation, Chest Disease Research Institute, Kyoto University, Japan.

We present the first reported case of Mycobacterium szulgai pulmonary disease that needed surgical resection due to unsuccessful antimycobacterial chemotherapy. The patient was a non-immunocompromised 48-year-old male who presented with hemoptysis and whose sputum cultures repeatedly yielded M. szulgai. Antimycobacterial chemotherapy with isoniazid (INH) and rifampin (RMP)/ethambutol (EMB) for three years had been unsuccessful, and subsequent chemotherapy with RMP, EMB, ethionamide and kanamycin had to be discontinued due to liver dysfunction. Surgical resection was finally performed, and resulted in a favorable outcome. Although M. szulgai pulmonary disease is usually well controlled by antimycobacterial chemotherapy alone, surgical treatment may be necessary in some cases.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005000 Ethionamide A second-line antitubercular agent that inhibits mycolic acid synthesis. Amidazine,Ethioniamide,Trecator,Trecator-SC,Trecator SC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
October 1999, Kekkaku : [Tuberculosis],
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
July 2016, QJM : monthly journal of the Association of Physicians,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
June 2017, Archivos de bronconeumologia,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
January 2019, SAGE open medical case reports,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
September 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
May 2002, Kekkaku : [Tuberculosis],
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
September 2012, Irish medical journal,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
May 2002, Kekkaku : [Tuberculosis],
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
January 1991, Revue des maladies respiratoires,
K Tsuyuguchi, and R Amitani, and H Matsumoto, and E Tanaka, and K Suzuki, and K Yanagihara, and H Mizuno, and S Hitomi, and F Kuze
November 1998, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!